Divi's Laboratories Limited (DIVISLAB.BO)

INR 5849.2

(0.02%)

Market Cap (In INR)

1552.78 Billion

Revenue (In INR)

78.45 Billion

Net Income (In INR)

16 Billion

Avg. Volume

12.28 Thousand

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3350.05-6448.75
PE
-
EPS
-
Beta Value
0.349
ISIN
INE361B01024
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Dr. Kiran Satchandra Divi B. Pharm., M.Pharm
Employee Count
-
Website
https://www.divislabs.com
Ipo Date
Details
Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, North America, Asia, Europe, and internationally. It also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, and canthaxanthin, as well as other finished forms, including lutein, and vitamins to food, dietary supplement, and feed manufacturers industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad, India.